China Inhaler Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
China inhaler market was valued at around $2.2 billion in 2018 and is anticipated to grow at a substantial rate of 3.3% during the forecast period. High level of air pollution and significant number of smokers in China is boosting the demand for inhalers in the country. Additionally, rising geriatric population susceptible to asthma and COPD within the country is also driving the demand for inhalers. During June 2012 to May 2015, a survey was conducted by the Ministry of Health and Ministry of Science and Technology of China. About 51,000 citizens participated in the survey with 21,500 men and 29,500 women, according to which, it was estimated that about 100 million adults in 2015 had problem of COPD in the country. The prevalence is higher in men as compared to women. As per the estimation, there were 68.4 million men and 31.5 million women affected by COPD.
To Request a Sample of our Report on China Inhaler Market: https://www.omrglobal.com/request-sample/china-inhaler-market
The China inhaler market is
segmented on the basis of device, type, application, and end-user. On the basis
of device, the market is sub-segmented into metered dosed inhaler, dry powdered
inhaler, and nebulizer. The dry powder inhaler is estimated to have largest
market share in the China inhaler market due to providing easy inhalation
solution. Whereas, the market for metered dose inhaler is estimated to be the
fastest growing at a CAGR during the forecast period owing to innovations and
collaborations by the companies for the development of metered dosed inhaler.
Based on the type, preventive, reliever, and long acting bronchodilators
inhaler are analyzed. Moreover, on the basis of application, the market has
been classified into asthma and COPD diseases. In addition, based on the
end-user, homecare and hospitals and clinics have been analyzed.
A
full Report of China Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/china-inhaler-market
China Inhaler
Market Segmentation
By
Device
·
Metered
Dose Inhaler
·
Dry
Powder Inhaler
·
Nebulizer
By Type
·
Preventive
Inhaler
·
Reliever
Inhaler
·
Long
Acting Bronchodilators Inhaler
By
Application
·
Asthma
·
Chronic
Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals
and Clinics
Company
Profiles
·
3M Co.
·
Adherium
Ltd.
·
Aradigm
Corp.
·
AstraZeneca
PLC
·
Boehringer
Ingelheim International GmbH
·
Cipla
Ltd.
·
Gerresheimer
AG
·
GlaxoSmithKline
PLC
·
Koninklijke
Philips N.V.
·
Novartis
AG
·
ResMed
Corp.
·
Sunovion
Pharmaceuticals
·
Teva
Pharmaceuticals Industries Ltd.
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/china-inhaler-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment